|
 |
| |
REGISTER TODAY FOR:
THE CLINICAL, REGULATORY AND
COMMERCIAL IMPLICATIONS
OF RAPID APPROVAL
12 July 2016 | London
|
|
|
- |
| |
Join us for executive roundtables exploring rapid approval options globally, their challenges, and the development innovations they have ignited.
Rapid approval presents noted opportunity in the U.S., Europe and Japan. Yet the varied nature and diversity of payer and regulatory landscapes in these regions are generating new and unanticipated challenges. Biopharmaceutical companies small to large are responding with development innovations worthy of discussion. |
|
| |
Partial Speaker List
- Professor Frank-Ulrich Fricke, Deputy Member of the GBA Pricing Arbitration Board
- Dr. David Gillen, Vice President, Head of International Medical Affairs, Vertex Pharmaceuticals (Europe) Limited
- Dr. Arup Pramanik, Global Head, Patient Access (Oncology), Baxalta
- James Ryan, Group Director, Health Economics & Payer Analytics (Oncology), AstraZeneca Global Product & Portfolio Strategy
- Joseph Scheeren,
Senior Vice President, Head of Global Regulatory Affairs, Pharmaceuticals and Consumer Care, Bayer HealthCare
- Dr. David Thorne, Chief Executive, Newcastle Bridges Commissioning Consortium
- Dr. Richard Torbett, Executive Director, Commercial, The Association of the British Pharmaceutical Industry
View full agenda here. |
|
|
| |
Who Is Attending
C-suite Executives, Heads of R&D, Clinical Development, Medical Affairs, Regulatory Affairs, and Commercialization (Market Access, Reimbursement, HEOR)
Venue
St. Pancras Renaissance London Hotel
Euston Road
London NW1 2AR
United Kingdom |
|
| |
|
©2016 PAREXEL International Corp.
195 West Street Waltham, MA, 02451, USA • Tel: +1 781-487-9900
Privacy Policy | Contact Us
If you would like to change or modify your subscription preferences, click here. If you would like to unsubscribe from all PAREXEL marketing communications, click here.
©2016 PAREXEL International Corp.
This communication, including any attachments, is intended only for the person or entity to which it is addressed and may contain confidential material. Any review, retransmission, distribution or other use of this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please destroy any copies, contact the sender and delete the material from any computer. PAREXEL and Your Journey. Our Mission. are registered trademarks of PAREXEL International Corporation or its affiliates in the United States and other jurisdictions.
|
|
